Arthur A. Hurwitz

5.5k total citations · 3 hit papers
44 papers, 4.2k citations indexed

About

Arthur A. Hurwitz is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Arthur A. Hurwitz has authored 44 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Immunology, 27 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Arthur A. Hurwitz's work include Immunotherapy and Immune Responses (32 papers), T-cell and B-cell Immunology (18 papers) and Immune Cell Function and Interaction (17 papers). Arthur A. Hurwitz is often cited by papers focused on Immunotherapy and Immune Responses (32 papers), T-cell and B-cell Immunology (18 papers) and Immune Cell Function and Interaction (17 papers). Arthur A. Hurwitz collaborates with scholars based in United States, Italy and United Kingdom. Arthur A. Hurwitz's co-authors include James P. Allison, Andrea van Elsas, Eugene D. Kwon, Norman M. Greenberg, Barbara A. Foster, Dana R. Leach, Maurice B. Burg, William D. Lyman, Stephanie K. Watkins and Tan Truong and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and The Journal of Experimental Medicine.

In The Last Decade

Arthur A. Hurwitz

44 papers receiving 4.1k citations

Hit Papers

Combination Immunotherapy of B16 Melanoma Using Anti–Cyto... 1997 2026 2006 2016 1999 2000 1997 250 500 750

Peers

Arthur A. Hurwitz
Jeong Kim United States
Andrea Schietinger United States
John M. Herndon United States
Jianda Yuan United States
Cora D. Arthur United States
Firouzeh Korangy United States
Laura Strauss United States
Catherine Koebel United States
Jeong Kim United States
Arthur A. Hurwitz
Citations per year, relative to Arthur A. Hurwitz Arthur A. Hurwitz (= 1×) peers Jeong Kim

Countries citing papers authored by Arthur A. Hurwitz

Since Specialization
Citations

This map shows the geographic impact of Arthur A. Hurwitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arthur A. Hurwitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arthur A. Hurwitz more than expected).

Fields of papers citing papers by Arthur A. Hurwitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arthur A. Hurwitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arthur A. Hurwitz. The network helps show where Arthur A. Hurwitz may publish in the future.

Co-authorship network of co-authors of Arthur A. Hurwitz

This figure shows the co-authorship network connecting the top 25 collaborators of Arthur A. Hurwitz. A scholar is included among the top collaborators of Arthur A. Hurwitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arthur A. Hurwitz. Arthur A. Hurwitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burrack, Kristina S., Todd P. Knutson, Henrique Borges da Silva, et al.. (2021). CD8+ T cell self-tolerance permits responsiveness but limits tissue damage. eLife. 10. 9 indexed citations
2.
Aptsiauri, Natalia, Anahid Jewett, Arthur A. Hurwitz, Michael R. Shurin, & Viktor Umansky. (2016). Redefining cancer immunotherapy—optimization, personalization, and new predictive biomarkers: 4th Cancer Immunotherapy and Immunomonitoring (CITIM) meeting, April 27–30, 2015, Ljubljana, Slovenia. Cancer Immunology Immunotherapy. 65(7). 875–883. 1 indexed citations
3.
McGray, AJ Robert, Robin Hallett, Stephanie L. Swift, et al.. (2013). Immunotherapy-induced CD8+ T Cells Instigate Immune Suppression in the Tumor. Molecular Therapy. 22(1). 206–218. 64 indexed citations
4.
Shurin, Michael R., Viktor Umansky, Anatoli Malyguine, et al.. (2013). Cellular and molecular pathways in the tumor immunoenvironment: 3rd Cancer Immunotherapy and Immunomonitoring (CITIM) meeting, 22–25 April 2013, Krakow, Poland. Cancer Immunology Immunotherapy. 63(1). 73–80. 6 indexed citations
5.
Shafer-Weaver, Kimberly, Michael J. Anderson, Katherine E. Stagliano, et al.. (2009). Cutting Edge: Tumor-Specific CD8+ T Cells Infiltrating Prostatic Tumors Are Induced to Become Suppressor Cells. The Journal of Immunology. 183(8). 4848–4852. 59 indexed citations
6.
Mazzucchelli, Renata, Julie A. Hixon, Rosanne Spolski, et al.. (2008). Development of regulatory T cells requires IL-7Rα stimulation by IL-7 or TSLP. Blood. 112(8). 3283–3292. 102 indexed citations
7.
Gabrilovich, Dmitry I. & Arthur A. Hurwitz. (2008). Tumor-induced immune suppression : mechanisms and therapeutic reversal. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 7 indexed citations
8.
Anderson, Michael J., Kimberly Shafer-Weaver, Norman M. Greenberg, & Arthur A. Hurwitz. (2007). Tolerization of Tumor-Specific T Cells Despite Efficient Initial Priming in a Primary Murine Model of Prostate Cancer. The Journal of Immunology. 178(3). 1268–1276. 77 indexed citations
9.
Shafer-Weaver, Kimberly, Michael J. Anderson, Anatoli Malyguine, & Arthur A. Hurwitz. (2007). T Cell Tolerance to Tumors and Cancer Immunotherapy. Advances in experimental medicine and biology. 601. 357–368. 10 indexed citations
10.
Allison, James P., Cynthia A. Chambers, Arthur A. Hurwitz, et al.. (2007). A Role for CTLA‐4‐Mediated Inhibitory Signals in Peripheral T Cell Tolerance?. Novartis Foundation symposium. 215. 92–102. 17 indexed citations
11.
Ji, Qingyong, David Gondek, & Arthur A. Hurwitz. (2005). Provision of Granulocyte-Macrophage Colony-Stimulating Factor Converts an Autoimmune Response to a Self-Antigen into an Antitumor Response. The Journal of Immunology. 175(3). 1456–1463. 20 indexed citations
12.
Roden, Anja C., Michael T. Moser, Maria Mercader, et al.. (2004). Augmentation of T Cell Levels and Responses Induced by Androgen Deprivation. The Journal of Immunology. 173(10). 6098–6108. 206 indexed citations
13.
Hurwitz, Arthur A., et al.. (2003). Prostate Cancer. BioDrugs. 17(2). 131–138. 12 indexed citations
14.
Vesosky, Bridget & Arthur A. Hurwitz. (2003). Modulation of costimulation to enhance tumor immunity. Cancer Immunology Immunotherapy. 52(11). 663–669. 17 indexed citations
15.
Evans, Dean E., Rodney A. Prell, Colin Thalhofer, Arthur A. Hurwitz, & Andrew D. Weinberg. (2001). Engagement of OX40 Enhances Antigen-Specific CD4+ T Cell Mobilization/Memory Development and Humoral Immunity: Comparison of αOX-40 with αCTLA-4. The Journal of Immunology. 167(12). 6804–6811. 82 indexed citations
16.
Hurwitz, Arthur A., Eugene D. Kwon, & Andrea van Elsas. (2000). Costimulatory wars: the tumor menace. Current Opinion in Immunology. 12(5). 589–596. 63 indexed citations
17.
Hurwitz, Arthur A., et al.. (1998). Enhancement of the anti-tumor immune response using a combination of interferon-γ and B7 expression in an experimental mammary carcinoma. International Journal of Cancer. 77(1). 107–113. 37 indexed citations
18.
Hurwitz, Arthur A., Timothy J. Sullivan, Matthew F. Krummel, Raymond A. Sobel, & James P. Allison. (1997). Specific blockade of CTLA-4/B7 interactions results in exacerbated clinical and histologic disease in an actively-induced model of experimental allergic encephalomyelitis. Journal of Neuroimmunology. 73(1-2). 57–62. 88 indexed citations
19.
Hurwitz, Arthur A., et al.. (1995). Tumor necrosis factor α and transforming growth factor β upregulate astrocyte expression of monocyte chemoattractant protein-1. Journal of Neuroimmunology. 57(1-2). 193–198. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026